Metformin and Ozempic: a comparative analysis in the management of prediabetes, weight loss and PCOS
Metformin and Ozempic: a comparative analysis in the management of prediabetes, weight loss and PCOS Metformin and Ozempic, both integral to the management of prediabetes, weight loss, and PCOS, demonstrate distinct mechanisms of action and varying degrees of efficacy in addressing these health concerns. Metformin: A mainstay of diabetes management Metformin, a cornerstone in the treatment of type 2 diabetes and prediabetes, works primarily by reducing insulin resistance. This key function helps control blood sugar levels, making it a widely prescribed drug in metabolic disorders. Although not initially marketed as a weight loss drug, metformin has been associated with weight loss in some individuals. In the context of PCOS, the effects of metformin extend beyond glycemic control. It regulates the menstrual cycle and hormone levels, addressing specific symptoms associated with PCOS such as irregular periods and hormonal imbalances. The specific mechanism involves improving insulin sens...